Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Pharming Group N.v. > Profile

Pharming Group N.v. (PHAR)

Market is closed
Sector: Healthcare
News See All
Pharming Group (PHAR) Expands Joenja's Pediatric Label. Can Growth Offset RUCONEST Weakness?

Pharming Group (PHAR) Expands Joenja's Pediatric Label. Can Growth Offset RUCONEST Weakness?

Pharming Group N.V. (NASDAQ:PHAR) announced on September 11 that the U.S.

Keep Reading →

September 16th, 2026 - Hedge Funds News

Pharming Group N.V. (NASDAQ:PHAR) Q1 2026 Earnings Call Transcript

Pharming Group N.V. (NASDAQ:PHAR) Q1 2026 Earnings Call Transcript May 7, 2026Pharming Group N.V. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $0.05.

Keep Reading →

May 8th, 2026 - News Transcripts

Pharming Group N.V. (NASDAQ:PHAR) Q3 2025 Earnings Call Transcript

Pharming Group N.V. (NASDAQ:PHAR) Q3 2025 Earnings Call Transcript November 6, 2025Pharming Group N.V. beats earnings expectations. Reported EPS is $0.1, expectations were $0.05.

Keep Reading →

November 7th, 2025 - News Transcripts

Click here to See All News
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.